News & Publications for:

Richard Perrin

Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer’s disease in a multicohort study

Posted on September 28, 2015

Leung, YY, et al.: 2015 Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 1(3), 339-348. DOI: 10.1016/j.dadm.2015.06.008 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: , ,

Cerebrospinal fluid biomarkers for clinical trials: why markers for differential diagnosis are important

Posted on July 23, 2013

Richard J. Perrin, MD, PhD; Arch Neurol. 2012;69(11):1407-1408. doi:10.1001/archneurol.2012.2353. Read More

Posted in: HPAN, Publications Faculty:

Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.

Posted on July 23, 2013

Richard J. Perrin,Jacqueline E. Payton, James P. Malone, Petra Gilmore, Alan E. Davis, Chengjie Xiong, Anne M. Fagan, R. Reid Townsend, and David M. Holtzman,
Dulce Elena Casarini, Editor; PLoS One. 2013; 8(5): e64314.Published online 2013 May 20. doi: 10.1371/journal.pone.0064314
Read More

Posted in: HPAN, Publications Faculty: , ,

Plasma multi-analyte profiling in mild cognitive impairment and Alzheimer’s disease

Posted on September 18, 2012

Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; For the Alzheimer’s Disease Neuroimaging Initiative (2012). Neurology, 79(9): 897-905 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: , ,